Corcept Therapeutics logo

Corcept Therapeutics

Pioneering the discovery and development of cortisol modulators.

798 employees · est. 1998 · Redwood City, United States

VS
Xanthus Pharmaceuticals logo

Xanthus Pharmaceuticals

Innovative treatments for cancer and autoimmune disorders through pioneering small-molecule therapeutics.

est. 2001

Corcept Therapeutics is the older company (1998 vs 2001).

Side-by-Side Comparison

Corcept Therapeutics Xanthus Pharmaceuticals
Founded
1998 older 2001
Headquarters
Redwood City, United States Not tracked yet
Employees
798 Not tracked yet
Industry
Biotechnology, Pharmaceutical Biopharma, Biotechnology, Pharmaceutical
Funding Stage
Post Ipo Equity Series B
Total Funding
$119.09M $76.20M
Funding Rounds
8 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Pharmaceuticals, Cortisol Modulation, Glucocorticoid Receptors Antagonists, FDA Approval, Treatment Development, Hypercortisolism, Cushing's Syndrome, Oncology, Endocrine Disorders, Metabolic Disorders, Collaborations, Global Partnerships, Scientific Research, Drug Development Biopharmaceutical, Cancer Treatment, Autoimmune Disorders, Small-molecule Therapeutics, Drug Discovery, Drug Development, Acquisition, Commercialization
Website
corcept.com xanthus.com
Corcept Therapeutics logo

About Corcept Therapeutics

Corcept Therapeutics is a biopharmaceutical company that has been pioneering the discovery and development of cortisol modulators since its founding in 1998. The company's mission is to unlock the potential of cortisol and revolutionize the treatment of serious diseases. Over the last 25 years, Cor...

Xanthus Pharmaceuticals logo

About Xanthus Pharmaceuticals

Xanthus Pharmaceuticals is a biopharmaceutical company founded in 2001 with a focus on discovering, developing, and commercializing small-molecule therapeutics for cancer and autoimmune disorders. The company's slogan reflects its dedication to pioneering innovative treatments for these challenging...

We will tell you when either one moves

BounceWatch watches Corcept Therapeutics and Xanthus Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Corcept Therapeutics and Xanthus Pharmaceutical... — by email.

Frequently Asked Questions

Corcept Therapeutics — Pioneering the discovery and development of cortisol modulators.. Xanthus Pharmaceuticals — Innovative treatments for cancer and autoimmune disorders through pioneering small-molecule therapeutics.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Corcept Therapeutics has raised $119.09M while Xanthus Pharmaceuticals has raised $76.20M.
Corcept Therapeutics and Xanthus Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Corcept Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Corcept Therapeutics on 11 Sep 2024, and Xanthus Pharmaceuticals on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes